🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neuroendocrine tumors (NETs) and cancers that originate from the gastrointe...
Status
Terminated
Location
Rocky Mountain Cancer Center
Start Date
2017-07-28
Trial ID
NCT02859064
Treatments Being Tested
The prognosis for patients with metastatic breast cancer has improved conti...
Status
Completed
Location
Universitätsmedizin Mannheim Klinik für Strahlentherapie und Radioonkologie
Start Date
2021-03-05
Trial ID
NCT04495309
Treatments Being Tested
This phase II trial studies how well prostate specific membrane antigen (PS...
Status
Recruiting
Location
University of Pittsburgh Cancer Institute (UPCI)
Start Date
2020-09-30
Trial ID
NCT04175431
This is clinical trial evaluating the safety and efficacy of radiotherapy c...
Status
Not Yet Recruiting
Location
West China Hospital of Sichuan University
Start Date
2026-10-31
Trial ID
NCT07258147
Randomized phase III trial to compare the effectiveness of two combination ...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2000-07
Trial ID
NCT00006011
Treatments Being Tested
The purpose of this study is to learn how well a combination of iparomlimab...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Start Date
2026-10-01
Trial ID
NCT07776080
This randomized phase III trial studies carboplatin and paclitaxel to see h...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-06-29
Trial ID
NCT00942357
At the moment there is a lack of data in the setting of oligometastatic PC ...
Status
Active Not Recruiting
Location
Humanitas Research Hospital
Start Date
2020-10-19
Trial ID
NCT04624828
Treatments Being Tested
Evaluation of the impact of metastasis-directed therapy in patients with ca...
Status
Recruiting
Location
University Hospitals Leuven
Start Date
2023-12-19
Trial ID
NCT06585007
Treatments Being Tested
STOP-2 is a phase III multi-institutional double-blind randomized trial. 19...
Status
Recruiting
Location
BC Cancer - Surrey
Start Date
2025-12-04
Trial ID
NCT06918951
Treatments Being Tested